783 SGN-PDL1V, a novel, investigational PD-L1-directed antibody-drug conjugate for the treatment of solid tumors

• Priyanka Gupta,
• Haley Neff-LaFord,
• Kelly Hensley,
• Sean Allred,
• Andres Forero-Torres,
• Byron Kwan,
• Megan Ramirez,
• Steven Jin,
• Changpu Yu,
• Serena Wo,
• Jessica Simmons,
• Christina Zuch de Zafra,
• Shawna Hengel,
• Heather Van Epps

Affiliations

Priyanka Gupta

Nyaya Health Nepal, Kathmandu, Nepal

Haley Neff-LaFord

Seattle Genetics, Bothell, WA, USA

Kelly Hensley

1Seattle Genetics, Inc., Bothell, USA

Sean Allred

1Seattle Genetics, Inc., Bothell, USA

Andres Forero-Torres

10Seagen Inc, Seattle, WA, USA

Byron Kwan

Seagen, Bothell, WA, United States

Megan Ramirez

Seagen, Bothell, WA, United States

Steven Jin

Seagen, Bothell, WA, United States

Changpu Yu

Seagen, Bothell, WA, United States

Serena Wo

Seagen, Bothell, WA, United States

Jessica Simmons

Seagen, Bothell, WA, United States

Christina Zuch de Zafra

Seagen, Bothell, WA, United States

Shawna Hengel

Seagen, Bothell, WA, United States

Heather Van Epps

Seagen, Bothell, WA, United States